Integrum AB, Invitation to the Third Quarter 2023, 24 Results Presentation - Marketscreener.com
| 688050 Stock | 90.01 0.60 0.66% |
About 61% of Eyebright Medical's investor base is looking to short. The analysis of overall sentiment of trading Eyebright Medical Technology stock suggests that many investors are alarmed at this time. The current market sentiment, together with Eyebright Medical's historical and current headlines, can help investors time the market. In addition, many technical investors use Eyebright Medical stock news signals to limit their universe of possible portfolio assets.
Eyebright |
Integrum AB, Invitation to the Third Quarter 2023, 24 Results Presentation Marketscreener.com
Read at news.google.com
 |
Eyebright Medical Fundamental Analysis
We analyze Eyebright Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eyebright Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eyebright Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Debt
Total Debt Comparative Analysis
Eyebright Medical is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Eyebright Medical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Eyebright Medical stock to make a market-neutral strategy. Peer analysis of Eyebright Medical could also be used in its relative valuation, which is a method of valuing Eyebright Medical by comparing valuation metrics with similar companies.
Peers
Eyebright Medical Related Equities
| 002149 | Western Metal | 1.27 | ||||
| 601020 | Tibet Huayu | 0.92 | ||||
| 000758 | China Nonferrous | 0.81 | ||||
| 300057 | Shantou Wanshun | 0.61 | ||||
| 600711 | Chengtun Mining | 0.43 | ||||
| 603697 | Youyou Foods | 0.40 | ||||
| 000688 | Guocheng Mining | 2.31 | ||||
| 600982 | Ningbo Thermal | 2.97 |
Complementary Tools for Eyebright Stock analysis
When running Eyebright Medical's price analysis, check to measure Eyebright Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eyebright Medical is operating at the current time. Most of Eyebright Medical's value examination focuses on studying past and present price action to predict the probability of Eyebright Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eyebright Medical's price. Additionally, you may evaluate how the addition of Eyebright Medical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |